Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Profilazione della sensibilità alle terapie…
JoVE Journal
Cancer Research

This content is Free Access.

JoVE Journal Cancer Research
Profilazione della sensibilità alle terapie mirate negli organoidi derivati dal paziente NSCLC EGFR-Mutant
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Journal (Cancer Research)
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
Journal (Cancer Research)
Phospholipid Mediator Induced Transformation in Three-Dimensional Cultures
 
Click here for the English version

Profilazione della sensibilità alle terapie mirate negli organoidi derivati dal paziente NSCLC EGFR-Mutant

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Questo protocollo descrive una valutazione standardizzata della sensibilità dei farmaci agli inibitori di segnalazione mirati in modelli di organoidi derivati dal paziente NSCLC.

Tags

Cancer Research Organoide organoide polmonare DOP NSCLC cancro del polmone osimertinib EGFR inibitore mirato resistenza
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter